5069Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI)

Authors

Lu G; Lin J; Bronson M; Crowther M; Conley PB; Curnutte JT

European Heart Journal, Vol. 39, No. suppl_1,

Oxford University Press (OUP)

August 1, 2018

10.1093/eurheartj/ehy566.5069

0195-668X

Mark Crowther